Author: Gemcioglu, Emin; Davutoglu, Mehmet; Catalbas, Ramis; Karabuga, Berkan; Kaptan, Enes; Aypak, Adalet; Kalem, Ayse K; Özdemir, Mustafa; Yeşilova, Necati Y; Kalkan, Emra A; Civak, Musa; Kücüksahin, Orhan; Erden, Abdulsamet; Ates, Ihsan
Title: Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission Cord-id: b2r4fvs3 Document date: 2021_5_11
ID: b2r4fvs3
Snippet: Aim: COVID-19 is a pandemic that causes high morbidity and mortality, especially in severe patients. In this study, we aimed to search and explain the relationship between biochemical markers, which are more common, easily available and applicable to diagnose and to stage the disease. Materials & methods: In this study, 609 patients were evaluated retrospectively. 11 biochemical parameters were included in analysis to explain the relationship with severity of disease. Results: Nearly, all the pa
Document: Aim: COVID-19 is a pandemic that causes high morbidity and mortality, especially in severe patients. In this study, we aimed to search and explain the relationship between biochemical markers, which are more common, easily available and applicable to diagnose and to stage the disease. Materials & methods: In this study, 609 patients were evaluated retrospectively. 11 biochemical parameters were included in analysis to explain the relationship with severity of disease. Results: Nearly, all the parameters that have been evaluated in this study were statistically valuable as a predictive parameter for severe disease. Areas under the curve of blood urea nitrogen (BUN)/albumin ratio (BAR), CALL score and lymphocyte/C-reactive protein ratio were 0.795, 0.778 and 0.770. The BUN/BAR and neutrophil/albumin ratios provide important prognostic information for decision-making in severe patients with COVID-19. Conclusion: High BUN/BAR and neutrophil/albumin ratios may be a better predictor of severity COVID-19 than other routinely used parameters in admission.
Search related documents:
Co phrase search for related documents- abdominal pain and liver damage: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- abdominal pain and liver dysfunction: 1, 2, 3, 4
- abdominal pain and liver patient: 1, 2, 3, 4, 5, 6, 7
- abdominal pain and local hospital: 1
- abdominal pain and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- abdominal pain and logistic regression model: 1, 2
- abdominal pain and low platelet count: 1, 2, 3, 4
- abdominal pain and lung disease: 1, 2, 3, 4, 5, 6, 7
- abdominal pain and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
- abdominal pain and lymphocyte crp: 1
- abdominal pain pain and acute phase: 1, 2
- abdominal pain pain and logistic regression: 1, 2, 3, 4, 5, 6
- abdominal pain pain and low platelet count: 1
- abdominal pain pain and lymphocyte count: 1
- abdominal pain pain diarrhea and lymphocyte count: 1
- active malignancy and liver disease: 1, 2, 3
- active malignancy and liver patient: 1
- active malignancy and logistic regression: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date